RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Myriad Genetics Stock

Myriad Genetics ROA 2024

Myriad Genetics ROA

-0.23

Ticker

MYGN

ISIN

US62855J1043

WKN

897518

In 2024, Myriad Genetics's return on assets (ROA) was -0.23, a 145.79% increase from the -0.09 ROA in the previous year.

Myriad Genetics Aktienanalyse

What does Myriad Genetics do?

Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Myriad Genetics's Return on Assets (ROA)

Myriad Genetics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Myriad Genetics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Myriad Genetics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Myriad Genetics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Myriad Genetics stock

What is the Return on Assets (ROA) of Myriad Genetics this year?

The Return on Assets (ROA) of Myriad Genetics is -0.23 undefined this year.

What was the ROA of Myriad Genetics compared to the previous year?

The ROA of Myriad Genetics has increased by 145.79% compared to the previous year.

What consequences do high ROA have for investors of Myriad Genetics?

A high ROA is advantageous for investors of Myriad Genetics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Myriad Genetics?

A low ROA can be unfavorable for investors of Myriad Genetics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Myriad Genetics affect the company?

An increase in ROA of Myriad Genetics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Myriad Genetics impact the company?

A reduction in the ROA of Myriad Genetics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Myriad Genetics?

Some factors that can influence the ROA of Myriad Genetics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Myriad Genetics important for investors?

The ROA of Myriad Genetics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Myriad Genetics take to improve ROA?

To improve ROA, Myriad Genetics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Myriad Genetics pay?

Over the past 12 months, Myriad Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Myriad Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Myriad Genetics?

The current dividend yield of Myriad Genetics is .

When does Myriad Genetics pay dividends?

Myriad Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Myriad Genetics?

Myriad Genetics paid dividends every year for the past 0 years.

What is the dividend of Myriad Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Myriad Genetics located?

Myriad Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Myriad Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Myriad Genetics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Myriad Genetics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Myriad Genetics in the year 2023?

In the year 2023, Myriad Genetics distributed 0 USD as dividends.

In which currency does Myriad Genetics pay out the dividend?

The dividends of Myriad Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Myriad Genetics

Our stock analysis for Myriad Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Myriad Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.